WallStreetZenWallStreetZen

NASDAQ: GPCR
Structure Therapeutics Inc Stock Ownership - Who owns Structure Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Structure Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Raymond C. StevensCHIEF EXECUTIVE OFFICER2024-06-1250,001$0.48
$24.00kBuy
Raymond C. StevensCHIEF EXECUTIVE OFFICER2024-06-1299,999$0.39
$39.00kBuy
Xichen LinCHIEF SCIENTIFIC OFFICER2024-06-03106,200$0.34
$36.11kBuy

1 of 1

GPCR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GPCR insiders and whales buy or sell their stock.

GPCR Shareholders

What type of owners hold Structure Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Wellington Management Group LLP4.53%7,785,614$163.89MInstitution
Fil Ltd3.76%6,473,761$136.27MInsider
Fmr LLC3.53%6,078,746$127.96MInstitution
Fmr LLC3.11%5,345,338$112.52MInsider
Janus Henderson Group PLC2.42%4,159,888$87.57MInstitution
Capital Research Global Investors2.06%3,537,341$74.46MInstitution
Ramy Farid1.90%3,260,495$68.63MInsider
Jun Yoon1.66%2,847,885$59.95MInsider
Deep Track Capital LP1.63%2,800,000$58.94MInstitution
Raymond C. Stevens1.56%2,688,264$56.59MInsider

1 of 3

GPCR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GPCR35.24%12.56%Net Buying
MDXG45.61%54.39%Net SellingNet Selling
ETNB83.07%11.13%Net BuyingNet Buying
SNDX91.75%8.25%Net SellingNet Selling
IOVA18.22%81.78%Net SellingNet Selling
View Top Biotech Stocks

Structure Therapeutics Stock Ownership FAQ

Who owns Structure Therapeutics?

Structure Therapeutics (NASDAQ: GPCR) is owned by 35.24% institutional shareholders, 12.56% Structure Therapeutics insiders, and 52.19% retail investors. Fil Ltd is the largest individual Structure Therapeutics shareholder, owning 6.47M shares representing 3.76% of the company. Fil Ltd's Structure Therapeutics shares are currently valued at $131.68M.

If you're new to stock investing, here's how to buy Structure Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.